Business
Platinum leads immuno-oncology company HaemaLogiX’s $10m round – The Australian Financial Review
Blood cancer immuno-oncology comapny HaemaLogiX is the latest to raise capital, bringing on Platinum Asset Management as its…
KappaMab is designed to enable the immune system to recognise the abnormal cancer cells and kill them.
Platinum Asset Management fund manager Bianca Ogden said the fund had been following the progress of HaemaLogiX and believed now was the right time to…
Continue Reading
-
Noosa News19 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News21 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News18 hours agoFranz Ferdinand: Australian Tour 2025
-
Business18 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week